普门科技(688389) - 2024 Q2 - 季度财报

Financial Performance - Total revenue for the first half of 2024 reached 590 million CNY, representing a year-on-year growth of 5.64%[24] - Net profit attributable to shareholders was 172 million CNY, with a year-on-year increase of 27.78%[24] - Operating cash flow net amount was 86 million CNY, showing a year-on-year growth of 33.81%[25] - The net profit margin for the first half of 2024 was 29.01%[8] - Return on equity (ROE) stood at 16.44%[15] Market Performance - Domestic market revenue was 429 million CNY, while international market revenue was 161 million CNY, with the latter showing a year-on-year growth of 18.26%[26] Research and Development - Research and development investment amounted to 99 million CNY, accounting for 16.74% of total revenue, an increase of 4.61 percentage points year-on-year[27] - The company holds a total of 220 authorized patents, including 52 invention patents[16] Product Development - The company launched several new products, including the LifoLas 8000 and LifoLas 9000 automated systems, enhancing its competitive edge in the market[27] Recognition and Awards - The company was recognized as a "Demonstration Enterprise for Smart Health and Elderly Care Applications" by multiple government departments[28]